SCHEMBL7844634

SCHEMBL7844634

CC(C)(C)OC(=O)NC[C@@]12CN(c3c(F)cc4c(=O)cc(C(=O)O)n(C5CC5)c4c3C#N)C[C@H]1CCO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7502244 0.85 KCNH2 (0.43)
SCHEMBL7494525 0.85 KCNH2 (0.34)
SCHEMBL7502250 0.83 KCNH2 (0.36)
SCHEMBL7842251 0.80 STAT3 (0.36)
SCHEMBL7995325 0.80 STAT3 (0.36)
SCHEMBL7836504 0.78 KCNH2 (0.46)
SCHEMBL7494366 0.78 KCNH2 (0.46)
SCHEMBL7836509 0.78 KCNH2 (0.46)
SCHEMBL7846924 0.78 KCNH2 (0.46)
SCHEMBL7846922 0.78 KCNH2 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010036941-A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders PETERSEN UWE (DE) 2001-11-01 US disclosed
US-6288081-B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith BAYER AKTIENGESELLSCHAFT (DE) 2001-09-11 US disclosed